FDA NDC Directory · JSON-LD · Markdown

Ezetimibe

NDC 76333-170 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerOrient Pharma Co., Ltd.
Marketing categoryAbbreviated NDA (generic) · App ANDA215693
Dosage form / routeTABLET · ORAL
Active ingredientsEZETIMIBE (10 mg/1)
Marketing started20220630
Package count4

External sources

Source: openFDA. Public-domain (CC0).